Intra-Cellular Ther (ITCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ITCI | AZN | AMGN | GILD | BMY |
| Company | Intra-Cellular Ther | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 131.90 | 170.64 | 369.23 | 131.83 | 61.40 |
| High | 131.98 | 170.89 | 371.00 | 132.86 | 61.70 |
| Low | 131.63 | 169.28 | 366.75 | 130.58 | 60.84 |
| Latest | 131.87 | 169.54 | 367.38 | 131.67 | 60.87 |
| Change | -0.05 | +0.20 | +1.14 | +1.39 | -0.06 |
| % Change | -0.04% | +0.12% | +0.31% | +1.07% | -0.10% |
| Volume | 16,062,900 | 941,289 | 383,024 | 1,644,232 | 2,318,445 |
| 20-Day Average Volume | 2,474,570 | 2,700,867 | 2,193,726 | 7,370,989 | 11,528,149 |
| Previous Close | 131.92 | 169.34 | 366.24 | 130.28 | 60.93 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 131.51 | 179.18 | 363.03 | 130.59 | 58.24 |
| 20-Day Raw Stochastic | 86.25% | 17.68% | 67.48% | 45.63% | 83.30% |
| 20-Day Relative Strength | 82.75 | 42.76 | 57.64 | 50.92 | 58.55 |
| Weighted Alpha | +83.21 | +6.10 | +21.17 | +10.20 | +27.57 |
| Today's Opinion | 100% Buy | 88% Sell | 72% Buy | 8% Sell | 72% Buy |
| Previous Opinion | 100% Buy | 88% Sell | 72% Buy | 32% Sell | 56% Buy |
| Last Month's Opinion | 100% Buy | 72% Sell | 24% Buy | 72% Sell | 24% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.13% since 03/25/25 | +0.84% since 07/15/26 | +2.69% since 07/15/26 | -0.23% since 07/15/26 | +3.94% since 07/15/26 |
| Low | 131.63 on 04/01/25 | 164.06 on 07/20/26 | 357.74 on 07/16/26 | 129.13 on 07/21/26 | 58.57 on 07/16/26 |
| High | 131.98 on 04/01/25 | 170.80 on 07/22/26 | 378.54 on 07/17/26 | 140.61 on 07/17/26 | 62.29 on 07/17/26 |
| 1-Month | |||||
| %Chg | +2.86% since 02/28/25 | -3.77% since 06/22/26 | +6.74% since 06/22/26 | +5.23% since 06/22/26 | +11.58% since 06/22/26 |
| Low | 131.18 on 03/05/25 | 164.06 on 07/20/26 | 345.49 on 06/23/26 | 123.67 on 06/25/26 | 54.78 on 06/24/26 |
| High | 131.98 on 04/01/25 | 196.41 on 07/02/26 | 378.54 on 07/17/26 | 140.61 on 07/17/26 | 62.29 on 07/17/26 |
| 3-Month | |||||
| %Chg | +57.89% since 12/31/24 | -12.85% since 04/22/26 | +6.37% since 04/22/26 | -1.13% since 04/22/26 | +3.80% since 04/22/26 |
| Low | 80.82 on 01/07/25 | 164.06 on 07/20/26 | 320.52 on 05/05/26 | 121.39 on 06/10/26 | 53.44 on 06/18/26 |
| High | 131.98 on 04/01/25 | 196.64 on 04/23/26 | 378.54 on 07/17/26 | 140.61 on 07/17/26 | 62.29 on 07/17/26 |
| 6-Month | |||||
| %Chg | +81.51% since 10/01/24 | -7.42% since 01/22/26 | +6.02% since 01/22/26 | +0.20% since 01/22/26 | +11.09% since 01/22/26 |
| Low | 70.90 on 10/07/24 | 164.06 on 07/20/26 | 320.52 on 05/05/26 | 121.39 on 06/10/26 | 53.44 on 06/18/26 |
| High | 131.98 on 04/01/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 14,047,056 | 262,630,736 | 197,662,656 | 161,751,728 | 124,423,392 |
| Shares Outstanding, K | 106,522 | 1,550,908 | 539,708 | 1,241,570 | 2,042,071 |
| Annual Sales | 680,850,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -74,680,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 199,220,000 | 15,288,000,000 | 8,618,000,000 | 6,960,000,000 | 11,489,000,000 |
| Last Quarter Net Income | -16,890,000 | 3,080,000,000 | 1,819,000,000 | 2,021,000,000 | 2,677,000,000 |
| 60-Month Beta | 0.46 | 0.24 | 0.41 | 0.32 | 0.23 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.16 on 02/21/25 | 2.58 on 04/29/26 | 5.15 on 04/30/26 | 2.03 on 05/07/26 | 1.58 on 04/30/26 |
| Earnings Date | 05/06/25 | 07/27/26 | 08/04/26 | 08/06/26 | 07/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 05/15/26 | 0.820 on 06/15/26 | 0.630 on 07/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 06/15/26 | 07/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.77 | 16.48 | 15.92 | 10.15 |